Acute Pancreatitis: An Unusual Side Effect of Adalimumab in Crohn’s Disease Patient
Background: Drug-induced acute pancreatitis is a rare condition occurs at an incidence rate of 0.1–1.4% and represents a diagnostic challenge. TNFα inhibitors specially adalimumab is very rarely reported in the literature, primarily through case reports, as a potential cause of acute pancreatitis. C...
Saved in:
Main Authors: | Walid El Ouardi, Mustapha Benazzouz |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Clinical Medicine Insights: Case Reports |
Online Access: | https://doi.org/10.1177/11795476251315000 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease
by: Yin-mei Fu, et al.
Published: (2017-01-01) -
Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
by: Remo Panaccione, et al.
Published: (2011-01-01) -
A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab
by: Hakan Ozkan, et al.
Published: (2013-01-01) -
Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease
by: Fang Wang, et al.
Published: (2025-01-01) -
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)